eCOA Vendor Localization Best Practices Checklist
One of the main challenges for pharma/biotech companies regarding clinical trials is prolonged eCOA study start-up.
It is paramount to choose the right eCOA platform for each study. Sponsors must consider the study’s specific needs, such as user-friendliness, compliance, and configurability. The investment of both time and money, not to mention protecting and upholding the integrity of the data collected, is critical when seeking regulatory approval and confirming drug safety and efficacy. A platform’s ability to handle localized content should also be a key component when determining which platform is the right fit for each study.
To start your journey in achieving faster study start-up timelines, download our recommended capabilities checklist.
